In this study, we demonstrated the therapeutic effects of CTRP1 in improving glucose homeostasis and preventing HFD-induced obesity, hyperglycemia, insulin resistance, and fatty liver in multiple metabolic disorder models. Here, C1QTNF1 is linked to Insulin resistance.